Samsara Bio Capital, LLC Catabasis Pharmaceuticals, Inc. Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
About Catabasis Pharmaceuticals, Inc.
- Ticker CATB
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,948,800
- Market Cap $657M